Advisor Group Holdings »

Context Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $980 500 1.96
2024-03-31 $2.1k 1.5k 1.38
2023-12-31 $1.7k 1.5k 1.13
2023-09-30 $2.3k 1.5k 1.51
2023-06-30 $2.4k 1.5k 1.60

More positions owned by Advisor Group Holdings

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding Context Therapeutics

Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Blue Owl Capital Holdings
Vanguard Group
Blackstone Group
Nantahala Capital Management
Franklin Resources
Alyeska Investment Group
Woodline Partners
Sio Capital Management
Affinity Asset Advisors
BlackRock
BlackRock

View all funds holding Context Therapeutics